Karl Erik Hellström

Karl Erik Hellström

Geen lopende functies

Health Technology

Profiel

Dr. Hellström received his M.D.
and Ph.D.
degrees from Karolinska Institute in Stockholm, Sweden, initially working in the area of tumor biology with an emphasis on immunogenetics.
As a student of George Klein, he was a member of the team that showed, for the first time, a tumor-destructive immune response to an animal's own autologous tumor.
After being recruited to the faculty of the University of Washington Medical School in 1966, Karl Erik Hellström and his wife, Dr. Ingegerd Hellström became internationally known after they reported that there is a T-lymphocyte-mediated immune response to human tumors, a discovery that opened new avenues for research and development of cancer therapy.

Eerdere bekende functies van Karl Erik Hellström

BedrijvenFunctieEinde
MARKER THERAPEUTICS, INC. Directeur/Bestuurslid 05-12-2005
SEAGEN INC. Directeur/Bestuurslid -
Ervaring van Karl Erik Hellström in detail bekijken

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Karl Erik Hellström in detail bekijken

Verwante bedrijven

Beursgenoteerde bedrijven1
MARKER THERAPEUTICS, INC.

Health Technology

Bedrijven in privébezit1

Health Technology

  1. Beurs
  2. Insiders
  3. Karl Erik Hellström